Literature DB >> 8507444

Independent effects of hyperinsulinemia and hyperglycemia on intracellular sodium in normal human red cells.

M Barbagallo1, R K Gupta, L M Resnick.   

Abstract

To study the contribution of glucose vis-à-vis insulin in the altered sodium homeostasis of diabetes mellitus, we utilized 23Na-NMR spectroscopy to noninvasively measure intracellular sodium (Nai) in red blood cells of non-diabetic, thin, normotensive subjects (n = 9), before and 60, 120, and 180 min after in vitro incubation with elevated glucose (15 mmol/L) and insulin (200 mumol/L) concentrations. Hyperglycemia caused a significant rise in Nai compared to basal values at 60 (9.1 +/- 0.8 to 9.7 +/- 0.8 mEq/L, P < .05), and 120 min (10.0 +/- 0.7 mEq/L, P < .05 v basal). Hyperinsulinemia induced a more pronounced and prolonged elevation of Nai. Significant elevations occurred at 60 (8.0 +/- 0.5 to 10.2 +/- 0.7 mEq/L, P < .05), 120 (10.5 +/- 1.1) mEq/L, P < .05 v basal), and 180 (9.1 +/- 0.5 mEq/L, P < .05 v basal) minutes. Thus, both hyperinsulinemia, and to a lesser extent, hyperglycemia cause intracellular sodium accumulation in normal human red cells. Since glucose transport in red cells is not insulin-dependent, insulin and glucose presumably exert their effects independently. Altogether, we suggest that these insulin- and glucose-mediated effects on cellular sodium, if present in other tissues as well, may underlie the increased total body sodium and the salt-dependent hypertension characteristic of chronic diabetic or hyperinsulinemic syndromes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507444     DOI: 10.1093/ajh/6.4.264

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  2 in total

1.  Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.

Authors:  Yingchun Han; Edward Randell; Sudesh Vasdev; Vicki Gill; Vereesh Gadag; Leigh Anne Newhook; Marie Grant; Donna Hagerty
Journal:  Mol Cell Biochem       Date:  2007-06-27       Impact factor: 3.396

2.  Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin.

Authors:  Arshpreet Kaur; Stephen J Winters
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.